Jun 1st 2020

FDA Issues Emergency Use Authorization for Impella RP as Therapy for COVID-19 Patients with Right Heart Failure (Cath Lab Digest)

Coronary

The United States Food and Drug Administration has issued an emergency use authorization for Impella RP to include patients suffering from COVID-19 related right heart failure or decompensation, including pulmonary embolism.